Characterizing the Conformations and Neurotoxic Species of Huntingtin
亨廷顿蛋白的构象和神经毒性种类的表征
基本信息
- 批准号:10814676
- 负责人:
- 金额:$ 62.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAffectAntibodiesAntibody TherapyBindingBiochemicalBiologicalBiological AssayBiophysicsBrainClassificationCollectionCryoelectron MicroscopyDevelopmentDiagnosticDiseaseDisease ProgressionEpitopesExonsHumanHuntington DiseaseHuntington geneIn VitroInheritedInjectionsInterventionKnowledgeLengthLibrariesLinkMapsMeasuresMediatingMethodologyMethodsModelingMolecularMolecular ConformationMonoclonal AntibodiesMusNerve BlockNerve DegenerationNeurodegenerative DisordersNeuronsOutcomePathogenesisPathogenicityPathologyPathway interactionsPatientsPhysiologicalPlasmaProductionPropertyProteinsProtocols documentationReagentRecombinant AntibodyRecombinantsResearchResolutionRoleSeverity of illnessSpecimenStructureTestingTherapeuticTimeToxic effectbiophysical techniquesconformerdiagnostic assaydiagnostic platformexperimental studyextracellularin vivoinnovationinsightmonomermouse modelmutantneuralneurotoxicneurotoxicitynew therapeutic targetnovelphysical statepolyglutaminepreventproteostasisreceptortargeted treatmenttherapeutic targettherapy developmenttool
项目摘要
The exon-1 of mutant huntingtin protein (mHTTex1) accumulates in the brains of Huntington’s disease (HD)
patients and is implicated in neurodegeneration. The intrinsically disordered mHTTex1 misfolds into a
heterogeneous mixture of assemblies, however, the pathogenic conformers are not well characterized. The
major limiting factors have been the lack of methods to assemble ultrapure mHTTex1 structures, molecular
tools to identify them and models to investigate their neurotoxicity. Towards this end, we have developed
protocols to assemble distinct oligomers, protofibrils and fibrils of mHTTex1 and have generated libraries of
monoclonal antibodies (mAbs) to defined structures. We plan to characterize the binding of representative
mAbs to conformations in various assemblies using biophysical and biochemical methods, explore whether the
interaction of each mAb with its epitope affects the misfolding, seeding and aggregation in vitro, and examine
the structures of mHTTex1 species upon binding to selected mAbs (aim 1). We have further developed a
diagnostic platform to study the entry of structurally known mHTTex1 species into human neurons and their
aggregation into neurotoxic assemblies. With this model, we plan to identify and characterize the
neuroinvasive/neurotoxic species of mHTTex1, map their pathogenic conformations and determine their
structures with biophysical methods including Cryo-EM. Moreover, we plan to discover the neuronal receptors,
which participate in the entry of mHTTex1 and identify the interacting proteins, which are incorporated in the
neurotoxic aggregates. In addition, we plan to examine for the presence of neuroinvasive mHTT species in the
brains of HD patients and in human neuronal and mouse models of HD to validate the physiological relevance
of the in vitro-assembled structures and any links to disease severity. These experiments may for the first time
identify the structures of neurotoxic mHTTex1 at high resolution, a novel pathway for their production, and may
provide targets for therapy development (aim 2). In aim 3, we will investigate the role extracellular mHTT in
disease in the CNS of HD mice. In one set of experiments, we plan to inject neuroinvasive species of
mHTTex1 into the brains of asymptomatic R6/2Q51 HD mice (express human mHTTex1 with 51Qs) and
investigate their ability to enter neurons, trigger assembly formation and accelerate disease progression.
Moreover, we will determine whether blocking any of the pathogenic conformations of mHTTex1 by AAV-
mediated delivery of recombinant antibodies, which are secreted in the CNS, inhibits the entry, amplification
and neurotoxicity of the injected species. Finally, given that mHTT is present in the CSF and plasma of HD
patients and mouse models, we plan to investigate the therapeutic impacts of secreted recombinant antibodies
on the accumulation of pathogenic mHTT assemblies and progression of HD-like pathology in the Q140 HD
mice expressing full-length mHTT. These studies will fill some of the knowledge gaps on the role of
extracellular mHTT in the pathogenesis of HD and may provide therapeutic targets and reagents.
突变的亨廷顿蛋白外显子1 (mHTTex1)在亨廷顿病(HD)患者的大脑中积累
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Amplification of neurotoxic HTTex1 assemblies in human neurons.
- DOI:10.1016/j.nbd.2021.105517
- 发表时间:2021-11
- 期刊:
- 影响因子:6.1
- 作者:Chongtham A;Isas JM;Pandey NK;Rawat A;Yoo JH;Mastro T;Kennedy MB;Langen R;Khoshnan A
- 通讯作者:Khoshnan A
Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1.
- DOI:10.1016/j.jbc.2023.105585
- 发表时间:2024-01
- 期刊:
- 影响因子:4.8
- 作者:Pandey, Nitin K;Varkey, Jobin;Ajayan, Anakha;George, Gincy;Chen, Jeannie;Langen, Ralf
- 通讯作者:Langen, Ralf
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ali Khoshnan其他文献
Ali Khoshnan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ali Khoshnan', 18)}}的其他基金
Characterizing the Conformations and Neurotoxic Species of Huntingtin
亨廷顿蛋白的构象和神经毒性种类的表征
- 批准号:
10447659 - 财政年份:2021
- 资助金额:
$ 62.98万 - 项目类别:
Characterizing the Conformations and Neurotoxic Species of Huntingtin
亨廷顿蛋白的构象和神经毒性种类的表征
- 批准号:
10316055 - 财政年份:2021
- 资助金额:
$ 62.98万 - 项目类别:
Validation of IKKbeta as a therapeutic target for HD
验证 IKKbeta 作为 HD 治疗靶点
- 批准号:
8697149 - 财政年份:2011
- 资助金额:
$ 62.98万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 62.98万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 62.98万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 62.98万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 62.98万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 62.98万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 62.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 62.98万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 62.98万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 62.98万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 62.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists